Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The head of the Food and Drug Administration cited a long commute and time away from family as reasons to step down.
A roundup of statements
A look at the 2019 State of the Union address
Four out of 10 FDA workers are sidelined.
For the second year, the White House ignores the group of Americans most affected by HIV. And that’s not the only omission.
Don’t delay! But be aware of these changes to the 2019 Affordable Care Act marketplace.
Up to $266 million to be moved from a number of health programs. Here’s how you can help stop it.
We will never end the HIV and hepatitis epidemics by preventing people with preexisting conditions from accessing care.
Advocacy group AIDS United is working to confirm that current Ryan White HIV funding is not affected by the Trump policy.
Legal experts claim the attack is “absurd.” But the Trump administration supports it.
Stocks of drug companies are rising—and that’s not a good sign for consumers.
A new law in Iowa allows “health benefit plans” that don’t meet federal insurance requirements.
Brenda Fitzgerald faced other questions about conflicts of interest. Anne Schuchat has been named the CDC’s acting director.
That assertion is a “complete mischaracterization of discussions,” says an HHS spokesperson.
U.S. lawmakers say appointing Azar is like putting “the pharmaceutical fox in charge of the health care henhouse.”
Last week, the president announced that biosimilar drugs would no longer get special incentives on state Medicaid markets.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.